Fortress Biotech, Inc. 4
4 · Fortress Biotech, Inc. · Filed Sep 19, 2016
Insider Transaction Report
Form 4
Avgerinos George
SVP, Biologics Operations
Transactions
- Sale
Common Stock, par value $0.001
2016-09-15$2.54/sh−15,000$38,100→ 293,000 total - Sale
Common Stock, par value $0.001
2016-09-16$2.55/sh−33,912$86,476→ 259,088 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades ranging from $2.49 to $2.58. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]This transaction was executed in multiple trades ranging from $2.53 to $2.62. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.